LIN
Linde Plc
NASDAQ · Basic Materials · Chemicals - Specialty · GB
$460.40
+0.42%Next report
Analyst consensus
- Next report date
- Oct 30, 2026
- EPS estimate
- $4.52
- Revenue estimate
- $9.2B
Latest reported
- Last report date
- Jul 31, 2026
- EPS actual
- $4.50
- EPS estimate
- $4.49
- Revenue actual
- $9.3B
- Revenue estimate
- $9.0B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 5
- Avg surprise (4Q)
- +0.7%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Strong Buy
- Price target
- $552
- PT range
- $525 – $580
- Analysts
- 7
7 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 31, 2026 | $4.49 | $4.50 | Beat 0.27% | $9.3B |
| May 1, 2026 | $4.27 | $4.33 | Beat 1.45% | $8.8B |
| Feb 5, 2026 | $4.18 | $4.20 | Beat 0.48% | $8.8B |
| Oct 31, 2025 | $4.18 | $4.21 | Beat 0.72% | $8.6B |
| Aug 1, 2025 | $4.03 | $4.09 | Beat 1.49% | $8.5B |
| May 1, 2025 | $3.92 | $3.95 | Beat 0.77% | $8.1B |
| Feb 6, 2025 | $3.94 | $3.97 | Beat 0.76% | $8.3B |
| Oct 31, 2024 | $3.89 | $3.94 | Beat 1.29% | $8.4B |
| Aug 2, 2024 | $3.78 | $3.85 | Beat 1.85% | $8.3B |
| May 2, 2024 | $3.68 | $3.75 | Beat 1.90% | $8.1B |
| Oct 26, 2023 | $3.57 | $3.63 | Beat 1.68% | $8.2B |
| Jul 27, 2023 | $3.48 | $3.57 | Beat 2.53% | $8.2B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 30, 2026